{"id":4330,"date":"2018-05-18T15:53:28","date_gmt":"2018-05-18T19:53:28","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4330"},"modified":"2018-05-18T15:54:17","modified_gmt":"2018-05-18T19:54:17","slug":"ipo-pipeline-update-bjs-wholesale-files-for-ipo","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-bjs-wholesale-files-for-ipo\/","title":{"rendered":"IPO Pipeline Update: BJ’s Wholesale files for IPO"},"content":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of May 18, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Screen<\/a><\/p>\n

NEW FILINGS<\/strong><\/span><\/p>\n

Company: M17 Entertainment Limited
\nSymbol: YQ
\nDescription: They operate the largest live streaming platform by revenue in Developed Asia with a market share of 19.2% in the first quarter of 2018, according to Frost & Sullivan.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Citigroup, Deutsche Bank Securities
\nCo-Manager(s): Daiwa Capital Markets, Mizuho Securities
\nTerms Added: 5-11-18
\nListed Cash Raise: $115m<\/p>\n

Company: MeiraGTx Holdings plc
\nSymbol: MGTX
\nDescription: They are a vertically integrated, clinical stage gene therapy company with four ongoing clinical programs and a broad pipeline of preclinical and research programs.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): BofA Merrill Lynch, Barclays, Evercore ISI
\nCo-Manager(s): Chardan
\nTerms Added: 5-14-18
\nListed Cash Raise: $86.25m<\/p>\n

Company: BJ\u2019s Wholesale Club Holdings, Inc.
\nSymbol: BJ
\nDescription: BJ\u2019s Wholesale Club is a leading warehouse club operator on the East Coast of the United States.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): BofA Merrill Lynch, Deutsche Bank, Goldman Sachs, J.P. Morgan
\nFiled: 5-17-18
\nListed Cash Raise: $100m<\/p>\n

Company: Adaptive Insights, Inc.
\nSymbol: ADIN
\nDescription: They are a leading provider of cloud-based software to modernize business planning.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Jefferies, RBC Capital
\nCo-Manager(s): JMP Securities, Oppenheimer & Co.
\nFiled: 5-17-18
\nListed Cash Raise: $100m<\/p>\n

TERMS ADDED<\/strong><\/span><\/p>\n

Company: Scholar Rock Holding Corporation
\nSymbol: SRRK
\nDescription: They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
\nTrade Date: 5\/24
\nShares: 5.36 million
\nPrice Range: $13.00-$15.00
\nUnderwriter(s): Jefferies, Cowen, BMO Capital
\nCo-Manager(s): Wedbush PacGrow
\nTerms Added: 5-14-18<\/p>\n

Company: Kiniksa Pharmaceuticals, Ltd.
\nSymbol: KNSA
\nDescription: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
\nTrade Date: 5\/24
\nShares: 7 million
\nPrice Range: $17.00-$19.00
\nUnderwriter(s): Goldman Sachs, J.P. Morgan
\nCo-Manager(s): JMP Securities, Wedbush PacGrow
\nTerms Added: 5-14-18<\/p>\n

Company: GreenSky, Inc.
\nSymbol: GSKY
\nDescription: They are a leading technology company that powers commerce at the point of sale.
\nTrade Date: 5\/24
\nShares: 34.1 million
\nPrice Range: $21.00-$23.00
\nUnderwriter(s): Goldman Sachs & Co., J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Citigroup, Credit Suisse, SunTrust Robinson Humphrey
\nCo-Manager(s): Raymond James, Sandler O’ Neill, Fifth Third Securities, Guggenheim Securities
\nTerms Added: 5-14-18<\/p>\n

Company: Iterum Therapeutics plc
\nSymbol: ITRM
\nDescription: They are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally.
\nTrade Date: 5\/25
\nShares: 5.33 million
\nPrice Range: $14.00-$16.00
\nUnderwriter(s): Leerink Partners, RBC Capital Partners
\nCo-Manager(s): Guggenheim Securities, Needham & Co.
\nTerms Added: 5-16-18<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of May 18, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: M17[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4330","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4330"}],"version-history":[{"count":4,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4330\/revisions"}],"predecessor-version":[{"id":4336,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4330\/revisions\/4336"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}